ClinicalTrials.Veeva

Menu
P

Psychiatric Associates | Overland Park, KS

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

SHP465
Viloxazine
Dasotraline
Rapastinel
Lisdexamfetamine dimesylate
Lisdexamfetamine Dimesylate
SPD489
SPN-812
Eszopiclone
Guanfacine Hydrochloride

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 51 total trials

A Trial of Centanafadine Long-term Safety in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD)

The primary purpose of this trial is to evaluate the safety and tolerability of centanafadine QD XR in pediatric subjects with ADHD.

Active, not recruiting
Attention Deficit/Hyperactivity Disorder
Drug: Centanafadine Hydrochloride

Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea...

Invitation-only
Migraine
Drug: Ubrogepant

Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea...

Enrolling
Migraine
Drug: Placebo-Matching Ubrogepant
Drug: Ubrogepant

Trial sponsors

Shire logo
Sumitomo Pharma logo
Supernus Pharmaceuticals logo
AbbVie logo
Allergan logo
Otsuka logo
Pfizer logo
E
Forest Laboratories logo
N

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems